Meeting
2019 Genitourinary Cancers Symposium
The timing from perioperative chemotherapy and disease recurrence could have clinical impact on survival in bladder cancer patients treated with salvage chemotherapy.
Authors
Eiji Kikuchi
Department of Urology, Keio University School of Medicine, Tokyo, Japan
Eiji Kikuchi , Nozomi Hayakawa , Koichirou Ogihara , Minami Omura , Ryuichi Mizuno , Mototsugu Oya
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 444)
DOI
10.1200/JCO.2019.37.7_suppl.444
Abstract #
444
Poster Bd #
J15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Neoadjuvant chemotherapy plus radical cystectomy (NAC-RC) versus trimodality therapy (TMT) in early-stage small cell bladder cancer: Comparison of outcomes.
First Author: Karan Jatwani
Poster
2023 ASCO Genitourinary Cancers Symposium
Neoadjuvant chemotherapy (NAC) versus adjuvant chemotherapy (AC) in patients with clinically node-positive upper tract urothelial cancer (UTUC) who underwent radical nephroureterectomy (RNU).
First Author: Karan Jatwani
Poster
2023 ASCO Genitourinary Cancers Symposium
Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC).
First Author: Andrew B Katims
Poster
2020 Genitourinary Cancers Symposium
Oncological outcomes following radical cystectomy for urothelial carcinoma of the bladder with positive lymph nodes.
First Author: Seyedeh Sanam Ladi Seyedian